Angela Pirillo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemia.
Journal: Expert opinion on pharmacotherapy
Published: September 08, 2026
Homozygous familial hypercholesterolemia: Will new LDL-C-lowering drugs replace lipoprotein apheresis?
Journal: European journal of preventive cardiology
Published: April 28, 2026
From Child to Family: Rethinking Cascade Screening for Elevated Lipoprotein(a).
Journal: European journal of preventive cardiology
Published: March 23, 2026
Upfront Combination or Stepwise Escalation: Personalising LDL-C Reduction in Clinical Practice.
Journal: Current atherosclerosis reports
Published: February 03, 2026
The role of bempedoic acid in the management of dyslipidaemia in people with diabetes: an expert opinion of Italian diabetologists.
Journal: Cardiovascular diabetology
Published: February 02, 2026
Fibrates : Do They Still Have a Role in Therapy in 2025?
Journal: Current atherosclerosis reports
Published: December 03, 2025
The two faces of cholesteryl ester transfer protein inhibitors.
Journal: Current opinion in lipidology
Published: November 05, 2025
Efficacy and safety of bempedoic acid in the prevention of cardiovascular events: results of the CLEAR Outcomes study and subgroup analyses
Journal: Giornale italiano di cardiologia (2006)
Published: October 02, 2025
Are we underestimating the benefits of lipid-lowering therapies?
Journal: Pharmacological reviews
Published: September 29, 2025
Apolipoprotein B at the core: another step forward.
Journal: European heart journal
Published: September 05, 2025
PCSK9 reloaded: sirtuin-1 as a post-translational checkpoint for LDL-C control.
Journal: Cardiovascular research
Published: July 22, 2025
Last Updated: 09/26/2026